Saul Rosenthal just Obtained 12,018 shares of TICC Capital Corp. (TICC), be careful if you are short!; Aerie Pharmaceuticals Has 1.2 Sentiment

March 7, 2018 - By Jerrie Dane

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases. The company has market cap of $2.11 billion. The Company’s lead product candidate includes Rhopressa, a once-daily eye drop for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension. It currently has negative earnings. The firm is also developing Roclatan, a once-daily eye drop to reduce IOP that is in Phase III registration trials to treat patients with open-angle glaucoma and ocular hypertension.

According to an electronic form that was filled with the Security Exchange Commission on March 06, 2018, Saul Rosenthal, President and COO of Ticc Capital Corp and an insider, made a purchase of 12,018 shares of the company and paid for these approx. $74,116 US Dollars which is calculated with stock price per share of $6.2. This is not his first insider trade, in the last 30 days, he acquired another 63,529 shares worth $364,697 USD. Saul Rosenthal right now possess 1.12 million shares which are equivalent to about 2.20% of the Connecticut-Company’s market cap (total dollar market value of all company’s outstanding shares).

Investors sentiment increased to 1.23 in Q3 2017. Its up 0.13, from 1.1 in 2017Q2. It increased, as 8 investors sold TICC Capital Corp. shares while 22 reduced holdings. 17 funds opened positions while 16 raised stakes. 6.94 million shares or 11.19% less from 7.82 million shares in 2017Q2 were reported. Nine Chapters Cap Mngmt Ltd Limited Liability Company reported 15,000 shares. Citigroup invested 0% in TICC Capital Corp. (NASDAQ:TICC). Stratos Wealth Prtn holds 18,000 shares. Stephens Inc Ar accumulated 19,928 shares. Stifel Fincl holds 11,719 shares. Retail Bank Of Montreal Can invested in 0% or 377,000 shares. Shufro Rose & Ltd Limited Liability Company invested in 17,000 shares. Tudor Invest Et Al reported 29,756 shares. Lucus Advsr Lc owns 33,900 shares. Omers Administration Corporation stated it has 0% in TICC Capital Corp. (NASDAQ:TICC). Eagle Glob Advsrs Limited Liability Corporation reported 26,099 shares. Creative Planning invested in 34,219 shares or 0% of the stock. Pnc Grp reported 6,200 shares. Exane Derivatives holds 15,733 shares or 0.02% of its portfolio. Selz Cap Ltd holds 1% of its portfolio in TICC Capital Corp. (NASDAQ:TICC) for 727,000 shares.

TICC Capital Corp. is a business development company, operates as a closed-end, non-diversified management investment company. The company has market cap of $321.99 million. The firm invests in both public and private companies. It has a 7.58 P/E ratio. It invests in secured and unsecured senior debt, subordinated debt, junior subordinated debt, preferred stock, and common stock.

Since December 15, 2017, it had 10 insider purchases, and 0 selling transactions for $1.02 million activity. COHEN JONATHAN H bought 12,494 shares worth $70,822. Shares for $98,934 were bought by ROSENTHAL SAUL B on Tuesday, February 27.

Among 7 analysts covering TICC Capital (NASDAQ:TICC), 1 have Buy rating, 2 Sell and 4 Hold. Therefore 14% are positive. TICC Capital has $7.50 highest and $4 lowest target. $6.25’s average target is -0.64% below currents $6.29 stock price. TICC Capital had 10 analyst reports since August 5, 2015 according to SRatingsIntel. Barclays Capital maintained TICC Capital Corp. (NASDAQ:TICC) rating on Friday, March 11. Barclays Capital has “Equal-Weight” rating and $5 target. The company was downgraded on Tuesday, March 7 by National Securities. The firm has “Underweight” rating by Barclays Capital given on Wednesday, May 4. On Tuesday, December 5 the stock rating was downgraded by National Securities to “Sell”. The rating was downgraded by Maxim Group to “Hold” on Wednesday, August 5. The firm earned “Buy” rating on Monday, November 6 by Ladenburg Thalmann.

The stock increased 0.96% or $0.06 during the last trading session, reaching $6.29. About 188,078 shares traded. TICC Capital Corp. (NASDAQ:TICC) has risen 38.21% since March 7, 2017 and is uptrending. It has outperformed by 21.51% the S&P500.

Foresite Capital Management Ii Llc holds 32.95% of its portfolio in Aerie Pharmaceuticals, Inc. for 1.67 million shares. Dafna Capital Management Llc owns 116,770 shares or 3.52% of their US portfolio. Moreover, Senzar Asset Management Llc has 2.74% invested in the company for 231,200 shares. The New York-based Iguana Healthcare Management Llc has invested 2.71% in the stock. Sectoral Asset Management Inc, a Quebec – Canada-based fund reported 373,396 shares.